[Federal Register Volume 71, Number 7 (Wednesday, January 11, 2006)]
[Notices]
[Page 1733]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-164]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Order No. 1432]


Grant Of Authority For Subzone Status, Abbott Pharmaceuticals PR 
LTD. (APPR)/Abbott Diagnostics International Ltd. (formerly Abbott 
Health Products, Inc.)/Abbott Biotechnology LTD (ABL), (Pharmaceutical 
Products), Barceloneta, Puerto Rico

    Pursuant to its authority under the Foreign-Trade Zones Act of 
June 18, 1934, as amended (19 U.S.C. 81a-81u), the Foreign-Trade 
Zones Board (the Board) adopts the following Order:
    Whereas, the Foreign-Trade Zones Act provides for `` . . . the 
establishment . . . of foreign-trade zones in ports of entry of the 
United States, to expedite and encourage foreign commerce, and for 
other purposes,'' and authorizes the Foreign-Trade Zones Board to grant 
to qualified corporations the privilege of establishing foreign-trade 
zones in or adjacent to U.S. Customs ports of entry;
    Whereas, the Board's regulations (15 CFR Part 400) provide for the 
establishment of special-purpose subzones when existing zone facilities 
cannot serve the specific use involved, and when the activity results 
in a significant public benefit and is in the public interest;
    Whereas, the Puerto Rico Industrial Development Corporation, 
grantee of FTZ 7, has made application to the Board for authority to 
establish special-purpose subzone status at the pharmaceutical 
intermediate manufacturing plant of Abbott Pharmaceuticals PR LTD. 
(APPR), Abbott Diagnostics International Ltd. (formerly Abbott Health 
Products, Inc.), and Abbott Biotechnology LTD (ABL), located in 
Barceloneta, Puerto Rico (FTZ Docket 23-2005, filed 5-17-05);
    Whereas, notice inviting public comment has been given in the 
Federal Register (70 FR 30080, 5/25/05); and,
    Whereas, the Board adopts the findings and recommendations of the 
examiner's report, and finds that the requirements of the FTZ Act and 
the Board's regulations are satisfied, and that approval of the 
application is in the public interest;
    Now, therefore, the Board hereby grants authority for subzone 
status for activity related to pharmaceutical products at the 
manufacturing complex of Abbott Pharmaceuticals PR LTD. (APPR), Abbott 
Diagnostics International Ltd. (formerly Abbott Health Products, Inc.), 
and Abbott Biotechnology LTD (ABL), located in Barceloneta, Puerto Rico 
(Subzone 7I), as described in the application and Federal Register 
notice, and subject to the FTZ Act and the Board's regulations, 
including Sec.  400.28.
    Signed at Washington, DC, this 23rd day of December 2005.

Stephen J. Claeys,
Acting Assistant Secretary of Commercefor Import Administration, 
Alternate Chairman Foreign-Trade Zones Board
    Attest:
Dennis Puccinelli,
Executive Secretary.
[FR Doc. E6-164 Filed 1-10-06; 8:45 am]
BILLING CODE 3510-DS-S